These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15029481)

  • 41. Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis.
    Dodé C; Dürr A; Pêcheux C; Mouret JF; Belal S; Bachner L; Agid Y; Kaplan JC; Brice A; Feingold J
    C R Acad Sci III; 1993 Nov; 316(11):1374-80. PubMed ID: 8087617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Apolipoprotein E Genotypes on Huntington's Disease Phenotypes in a Han Chinese Population.
    Li XY; Zhang YB; Xu M; Cheng HR; Dong Y; Ni W; Li HL; Wu ZY
    Neurosci Bull; 2019 Aug; 35(4):756-762. PubMed ID: 30887245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).
    Hendricks AE; Latourelle JC; Lunetta KL; Cupples LA; Wheeler V; MacDonald ME; Gusella JF; Myers RH
    Am J Med Genet A; 2009 Jul; 149A(7):1375-81. PubMed ID: 19507258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3.
    Kambouris M; Bohlega S; Al-Tahan A; Meyer BF
    Am J Hum Genet; 2000 Feb; 66(2):445-52. PubMed ID: 10677304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Origins and evolution of Huntington disease chromosomes.
    Andrew SE; Hayden MR
    Neurodegeneration; 1995 Sep; 4(3):239-44. PubMed ID: 8581556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new DNA marker (D4S90) is located terminally on the short arm of chromosome 4, close to the Huntington disease gene.
    Youngman S; Sarfarazi M; Bucan M; MacDonald M; Smith B; Zimmer M; Gilliam C; Frischauf AM; Wasmuth JJ; Gusella JF
    Genomics; 1989 Nov; 5(4):802-9. PubMed ID: 2574148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ancient origin of the CAG expansion causing Huntington disease in a Spanish population.
    García-Planells J; Burguera JA; Solís P; Millán JM; Ginestar D; Palau F; Espinós C
    Hum Mutat; 2005 May; 25(5):453-9. PubMed ID: 15832309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.
    Myers RH; MacDonald ME; Koroshetz WJ; Duyao MP; Ambrose CM; Taylor SA; Barnes G; Srinidhi J; Lin CS; Whaley WL
    Nat Genet; 1993 Oct; 5(2):168-73. PubMed ID: 8252042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective study of the impact of lifestyle on age at onset of Huntington disease.
    Trembath MK; Horton ZA; Tippett L; Hogg V; Collins VR; Churchyard A; Velakoulis D; Roxburgh R; Delatycki MB
    Mov Disord; 2010 Jul; 25(10):1444-50. PubMed ID: 20629137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Late-onset and typical Huntington disease families from Crete have distinct genetic origins.
    Kartsaki E; Spanaki C; Tzagournissakis M; Petsakou A; Moschonas N; Macdonald M; Plaitakis A
    Int J Mol Med; 2006 Feb; 17(2):335-46. PubMed ID: 16391835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
    Semaka A; Creighton S; Warby S; Hayden MR
    Clin Genet; 2006 Oct; 70(4):283-94. PubMed ID: 16965319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.
    Tsai YC; Metzger S; Riess O; Soehn AS; Nguyen HP
    BMC Med Genet; 2012 Jun; 13():48. PubMed ID: 22720673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease.
    Alford RL; Ashizawa T; Jankovic J; Caskey CT; Richards CS
    Am J Med Genet; 1996 Dec; 66(3):281-6. PubMed ID: 8985488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
    Lee JM; Ramos EM; Lee JH; Gillis T; Mysore JS; Hayden MR; Warby SC; Morrison P; Nance M; Ross CA; Margolis RL; Squitieri F; Orobello S; Di Donato S; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Sequeiros J; Paulsen JS; ; Landwehrmeyer GB; ; Myers RH; ; MacDonald ME; Gusella JF;
    Neurology; 2012 Mar; 78(10):690-5. PubMed ID: 22323755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.
    Rubinsztein DC; Leggo J; Coles R; Almqvist E; Biancalana V; Cassiman JJ; Chotai K; Connarty M; Crauford D; Curtis A; Curtis D; Davidson MJ; Differ AM; Dode C; Dodge A; Frontali M; Ranen NG; Stine OC; Sherr M; Abbott MH; Franz ML; Graham CA; Harper PS; Hedreen JC; Hayden MR
    Am J Hum Genet; 1996 Jul; 59(1):16-22. PubMed ID: 8659522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age at onset in Huntington's disease: replication study on the association of HAP1.
    Karadima G; Dimovasili C; Koutsis G; Vassilopoulos D; Panas M
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1027-8. PubMed ID: 22698993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
    Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
    Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased recombination adjacent to the Huntington disease-linked D4S10 marker.
    Allitto BA; MacDonald ME; Bucan M; Richards J; Romano D; Whaley WL; Falcone B; Ianazzi J; Wexler NS; Wasmuth JJ
    Genomics; 1991 Jan; 9(1):104-12. PubMed ID: 1672283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does arterial hypertension influence the onset of Huntington's disease?
    Valcárcel-Ocete L; Fullaondo A; Alkorta-Aranburu G; García-Barcina M; Roos RAC; Hjermind LE; Saft C; Frontali M; Reilmann R; Rickards H; ; Zubiaga AM; Aguirre A
    PLoS One; 2018; 13(5):e0197975. PubMed ID: 29791508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.